Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CRVO
#4451
CervoMed Inc. Common Stock
4.0
4
USD
+0.75%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.75%
Monthly Change
-5.39%
6 month change
-50.79%
Year Change
-60.78%
Previous Close
4.0
1
Open
4.0
4
Bid
Ask
Low
4.0
4
High
4.0
4
Volume
4
Markets
US Stock Market
Healthcare
CRVO
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
2.04 M
2.04 M
2.04 M
6.17 M
8.7 M
9.26 M
—
Valuation ratios
Enterprise value
—
—
—
41.57 M
11.36 M
64.91 M
249.29 M
Price to earnings ratio
—
—
—
-9.8
-1.16
-2.65
-11.93
Price to sales ratio
—
—
—
2.98
1.94
17.83
44.4
Price to cash flow ratio
—
—
—
-2.86
-1.14
-3.05
-12.22
Price to book ratio
—
—
—
2.89
0.48
3.92
5.34
Enterprise value to EBITDA ratio
—
—
—
—
—
-2.23
—
Profitability ratios
Return on assets %
-0.51
-0.64
-0.69
-0.22
-0.38
-1.18
-0.9
Return on equity %
-0.57
-0.69
-0.77
-0.29
-0.42
-1.48
-1.07
Return on invested capital %
-644.96
-2 666.82
11.49 K
-211.81 K
-1.36 M
13.85 K
—
Gross margin %
—
100
—
100
100
100
400
Operating margin %
—
47.66 K
—
-109.35
-187.18
-706.22
-98.63 K
EBITDA margin %
—
31.26 K
—
—
—
-727.54
—
Net margin %
—
46.53 K
—
-30.4
-167.29
-673.06
-95.69 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
7.71
12.92
7.3
2.46
8.66
4.91
24.16
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
-0
0
0.44
0.37
0.12
0.1
Solvency ratios
Debt to assets ratio
—
—
—
0
—
—
—
Debt to equity ratio
—
—
—
0
—
—
—
Long term debt to total assets ratio
—
—
—
0
—
—
—
Long term debt to total equity ratio
—
—
—
0
—
—
—
Per share metrics
Operating cash flow per share
—
—
—
-2.8
-2.05
-2.59
-2.6
EBIT per share
—
—
—
-2.94
-2.26
-3.13
-3.14
EBITDA per share
—
—
—
—
—
-3.22
—
Total debt per share
—
—
—
0
—
—
—
Cash per share
—
—
—
2.93
4.82
2.31
13.05
Net current asset value per share
—
—
—
3.74
5.34
2.53
14.53
Tangible book value per share
—
—
—
2.77
4.86
2.02
12.54
Working capital per share
—
—
—
2.22
4.72
2.02
12.11
Book value per share
—
—
—
2.77
4.86
2.02
12.54
News
H.C. Wainwright reiterates CervoMed stock rating on conference data
CervoMed Inc. (CRVO) Reports Q4 Loss, Lags Revenue Estimates
Buy 2 ‘Strong Buy’ Biotech Stocks With 400%+ Upside, According to Wall Street - TipRanks.com
CervoMed sets 50mg dose for phase 3 dementia trial
Pharming Group Gears Up to Report Q4 Earnings: What's in the Cards?
CervoMed’s neflamapimod selected for UK ALS trial platform
Cantor Fitzgerald initiates CervoMed stock with Overweight rating
CervoMed’s DLB drug shows promise in phase 2b trial
CervoMed stock soars after promising dementia drug trial results
Neflamapimod reduces key neurodegeneration markers in DLB study
CervoMed Inc. (CRVO) Reports Q3 Loss, Misses Revenue Estimates
Atara Biotherapeutics (ATRA) Surges 10.0%: Is This an Indication of Further Gains?